Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank60
3Y CAGR-31.9%
5Y CAGR+8.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-31.9%/yr
vs -19.5%/yr prior
5Y CAGR
+8.4%/yr
Recent deceleration
Acceleration
-12.4pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.35M | +56.3% |
| 2024 | $5.34M | +57.6% |
| 2023 | $3.39M | -87.2% |
| 2022 | $26.44M | +387.1% |
| 2021 | $5.43M | -2.5% |
| 2020 | $5.57M | -89.1% |
| 2019 | $50.97M | -19.0% |
| 2018 | $62.92M | +661.6% |
| 2017 | $8.26M | -92.2% |
| 2016 | $105.82M | - |